These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 19370342)

  • 1. Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.
    Descamps A; Rousset C; Millan MJ; Spedding M; Delagrange P; Cespuglio R
    Psychopharmacology (Berl); 2009 Jul; 205(1):93-106. PubMed ID: 19370342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT
    Tchekalarova J; Kortenska L; Ivanova N; Atanasova M; Marinov P
    Psychopharmacology (Berl); 2020 Feb; 237(2):503-518. PubMed ID: 31720718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: a comparison to melatonin and to the 5-HT(2c) antagonist, S32006.
    Norman TR; Cranston I; Irons JA; Gabriel C; Dekeyne A; Millan MJ; Mocaër E
    Eur J Pharmacol; 2012 Jan; 674(1):27-32. PubMed ID: 22040921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V; Pandi-Perumal SR; Trahkt I; Spence DW; Poeggeler B; Hardeland R; Cardinali DP
    Int J Neurosci; 2009; 119(6):821-46. PubMed ID: 19326288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade.
    Millan MJ; Brocco M; Gobert A; Dekeyne A
    Psychopharmacology (Berl); 2005 Feb; 177(4):448-58. PubMed ID: 15289999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spike-Wave Discharges and Sleep-Wake States during Circadian Desynchronization: No Effects of Agomelatine upon Re-Entrainment.
    Smyk MK; van Luijtelaar G; Huysmans H; Drinkenburg WH
    Neuroscience; 2019 Jun; 408():327-338. PubMed ID: 30978380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration.
    Molteni R; Calabrese F; Pisoni S; Gabriel C; Mocaer E; Racagni G; Riva MA
    World J Biol Psychiatry; 2010 Mar; 11(2):148-53. PubMed ID: 20109111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the rat.
    Cespuglio R; Rousset C; Debilly G; Rochat C; Millan MJ
    Psychopharmacology (Berl); 2005 Oct; 181(4):639-52. PubMed ID: 15983796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats.
    Mairesse J; Silletti V; Laloux C; Zuena AR; Giovine A; Consolazione M; van Camp G; Malagodi M; Gaetani S; Cianci S; Catalani A; Mennuni G; Mazzetta A; van Reeth O; Gabriel C; Mocaër E; Nicoletti F; Morley-Fletcher S; Maccari S
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):323-38. PubMed ID: 22310059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT(2C) receptors.
    Millan MJ; Marin P; Kamal M; Jockers R; Chanrion B; Labasque M; Bockaert J; Mannoury la Cour C
    Int J Neuropsychopharmacol; 2011 Jul; 14(6):768-83. PubMed ID: 20946699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agomelatine in the tree shrew model of depression: effects on stress-induced nocturnal hyperthermia and hormonal status.
    Schmelting B; Corbach-Söhle S; Kohlhause S; Schlumbohm C; Flügge G; Fuchs E
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):437-47. PubMed ID: 23978391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agomelatine restores a physiological response to stress in the aged rat.
    Descamps A; Rousset C; Dugua H; Debilly G; Delagrange P; Cespuglio R
    Neurosci Lett; 2014 Apr; 566():257-62. PubMed ID: 24602983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats.
    Chagraoui A; Protais P; Filloux T; Mocaër E
    Psychopharmacology (Berl); 2003 Oct; 170(1):17-22. PubMed ID: 12904965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonergic drugs in clinical practice.
    Hardeland R; Poeggeler B; Srinivasan V; Trakht I; Pandi-Perumal SR; Cardinali DP
    Arzneimittelforschung; 2008; 58(1):1-10. PubMed ID: 18368944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agomelatine affects rat suprachiasmatic nucleus neurons via melatonin and serotonin receptors.
    Yang J; Jin HJ; Mocaër E; Seguin L; Zhao H; Rusak B
    Life Sci; 2016 Jun; 155():147-54. PubMed ID: 27269050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients.
    Quera-Salva MA; Lemoine P; Guilleminault C
    Hum Psychopharmacol; 2010 Apr; 25(3):222-9. PubMed ID: 20373473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light.
    Tchekalarova J; Stoynova T; Ilieva K; Mitreva R; Atanasova M
    Pharmacol Biochem Behav; 2018 Aug; 171():1-9. PubMed ID: 29807067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.
    Monti JM; Jantos H
    Eur J Pharmacol; 2006 Dec; 553(1-3):163-70. PubMed ID: 17059817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus.
    Soumier A; Banasr M; Lortet S; Masmejean F; Bernard N; Kerkerian-Le-Goff L; Gabriel C; Millan MJ; Mocaer E; Daszuta A
    Neuropsychopharmacology; 2009 Oct; 34(11):2390-403. PubMed ID: 19571795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.